Investors
People are different and so is their cancer, patients should be treated individually.
New The power of precision, For Every Oncologist, Today
With IndiTreat, 2cureX makes the testing of chemotherapeutic agents on patient-derived microtumors an operational reality.
Read
Latest News
2cureX receives important ISO 13485:2016 certification
Read more
Please click here to download our Articles of association
Interim Report Q2 2021
View previous reports
Interim Report Q3 2021
Year-End Report 2021
IndiTreat® supports genomic characterization of tumors with unique functional information of treatment resistance and sensitivity.
2cureX receives important ISO 13485:2016 certification